Suven Pharmaceuticals (BOM:543064) Days Sales Outstanding : 56.83 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Suven Pharmaceuticals Days Sales Outstanding?

Suven Pharmaceuticals's average Accounts Receivable for the three months ended in Dec. 2023 was ₹1,369 Mil. Suven Pharmaceuticals's Revenue for the three months ended in Dec. 2023 was ₹2,198 Mil. Hence, Suven Pharmaceuticals's Days Sales Outstanding for the three months ended in Dec. 2023 was 56.83.

The historical rank and industry rank for Suven Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

BOM:543064' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.32 Med: 48.3 Max: 147
Current: 38.32

During the past 5 years, Suven Pharmaceuticals's highest Days Sales Outstanding was 147.00. The lowest was 38.32. And the median was 48.30.

BOM:543064's Days Sales Outstanding is ranked better than
81.12% of 996 companies
in the Drug Manufacturers industry
Industry Median: 72.035 vs BOM:543064: 38.32

Suven Pharmaceuticals's Days Sales Outstanding increased from Dec. 2022 (28.67) to Dec. 2023 (56.83).

Suven Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Suven Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suven Pharmaceuticals Days Sales Outstanding Chart

Suven Pharmaceuticals Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

147.00

59.72

40.89

47.93

48.30

Suven Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															28.67	29.66	29.13	54.07	56.83

Competitive Comparison of Suven Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Suven Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suven Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suven Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Suven Pharmaceuticals's Days Sales Outstanding falls into.

Suven Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Suven Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (2363.723	+	1109.393)	/	2 )	/	13122.848	*	365
=	1736.558					/	13122.848	*	365
=	48.30

Suven Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1368.987	+	0)	/	1 )	/	2198.196	*	365 / 4
=	1368.987					/	2198.196	*	365 / 4
=	56.83

Suven Pharmaceuticals (BOM:543064) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Suven Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Suven Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Suven Pharmaceuticals (BOM:543064) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suven Pharmaceuticals Ltd (BOM:543064) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

SUVENPHAR:India

Address

3rd Floor, Road No. 5, Avenue 7, Banjara Hills, No. 8-2-334, SDE Serene Chambers, Hyderabad, TG, IND, 500034

Website

https://www.suvenpharm.com

Suven Pharmaceuticals Ltd is engaged in the development and manufacturing of Intermediates, Active Pharmaceutical Ingredients (API), specialty chemicals and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology and chemical companies. The company has single operating segment that is Pharmaceuticals Manufacturing & Services and its geographical segments include India; the USA; Europe and the Rest of the World. The company derives a majority of revenue from the Europe segment.

Suven Pharmaceuticals (BOM:543064) Headlines

No Headlines